Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-026251
Filing Date
2022-10-11
Accepted
2022-10-11 16:34:36
Documents
1
Period of Report
2022-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166552045769875.html 4  
1 FORM 4 wf-form4_166552045769875.xml 4 5194
  Complete submission text file 0001628280-22-026251.txt   6514
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Hart Jayne B. (Reporting) CIK: 0001519749 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 221304442